Influenza News and Research

Latest Influenza News and Research

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Scientists determine that infection with SARS-CoV-2 during the first trimester of pregnancy does not increase the risk of any specific congenital malformations.

9 Aug 2022

CDC and Task Force for Global Health to co-host 11th International Conference on Emerging Infectious Diseases

The Centers for Disease Control and Prevention and the Task Force for Global Health will co-host in person the 11th International Conference on Emerging Infectious Diseases August 7-10, 2022, at the Hyatt Regency Atlanta hotel in Atlanta, GA.

9 Aug 2022

OU researchers receive nearly $1 million NSF grants for pandemic prediction and prevention projects

Two groups of researchers at the University of Oklahoma have each received nearly $1 million grants from the National Science Foundation as part of its Predictive Intelligence for Pandemic Prevention initiative, which focuses on fundamental research and capabilities needed to tackle grand challenges in infectious disease pandemics through prediction and prevention.

8 Aug 2022

Gut microbiota-derived metabolites offer protection against SARS-CoV-2

A new study investigated how the gut microbiome confers immunity to mammalian hosts against SARS-CoV-2 intranasal infection by generating short-chain fatty acids.

5 Aug 2022

How does the flu vaccine affect the risk of contracting COVID-19?

A new study describes the association between the risk of contracting COVID-19 and the seasonal flu vaccine.

4 Aug 2022

A combined influenza and COVID-19 mRNA vaccine

A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,

3 Aug 2022

Analysis of monkeypox virus genomes suggests that it spread early and cryptically

A new study reports the identification of a cluster of monkeypox virus A.2 lineage genomes.

3 Aug 2022

UCI researchers develop novel test that detects specific SARS-CoV-2 variants with 100% accuracy

University of California, Irvine researchers have developed a COVID-19 test that detects and identifies specific SARS-CoV-2 variants with 100% accuracy.

3 Aug 2022

Lower efficacy of COVID-19 mRNA vaccines in patients with frailty

In a new study, researchers assessed the effectiveness of COVID-19 vaccination against hospitalization and deaths among veterans based on frailty status in the United States.

3 Aug 2022

Human anti-desmoglein 2 levels are associated with COVID-19 severity

In a new study, researchers assessed the association between anti-desmoglein (DSG) 1, 2 and 3 auto-antibodies (auto-Abs) in acute and convalescent serum samples obtained from patients with COVID-19 of varying severity.

2 Aug 2022

Pediatric adjuvant formulation offers protection against RSV in newborns

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

2 Aug 2022

Study aims to assess the accuracy of influenza rapid diagnostic tests

JMIR Publications recently published "Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study" in JMIR Public Health and Surveillance which reported that rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems.

2 Aug 2022

The time has come for DIY mandates on covid

Here we are in the grip of yet another covid-19 surge, yet most people I see out and about are behaving as if the pandemic is over. And I live in Los Angeles County, whose public health department is arguably one of the most vigilant and proactive in the U.S.

2 Aug 2022

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

Researchers measured the impact of initial respiratory droplet volume and relative humidity on the environmental stability of respiratory viruses, including influenza A and SARS-CoV-2.

2 Aug 2022

Study suggests possible benefit from melatonin in COVID-19

A new study discusses the utility of vitamin C and melatonin as potentially therapeutic and capable of preventing acute lung injury in COVID-19.

1 Aug 2022

What is the role of vitamin D in pandemic H1N1 influenza and SARS-CoV-2 infection?

A recent study published in Nutrients found that vitamin D is vital for lung protection from viral infection.

1 Aug 2022

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

Researchers evaluated the infectivity of two SARS-CoV-2 A lineage variants on human ocular tissues in vitro.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022